Skip to content

Clinical trials

Completed Phase 1/2 Hepatitis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Phase: Phase 1/2 Status: Completed Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20081
20111
20141
20151
20181
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vir Biotechnology, Inc.2
Ionis Pharmaceuticals, Inc.1
Russian Academy of Medical Sciences1
Tacere Therapeutics, Inc.1
University of Texas Southwestern Medical Center1
Vital Therapies, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis7
Hepatitis C, Chronic3
Hepatitis B2
Hepatitis B, Chronic2
Bronchiolitis Obliterans Syndrome1
Carcinoma, Hepatocellular1
Fibrosis1
Gastrointestinal Neoplasms1
Hepatitis C1
Hepatitis, Chronic1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.